Skip to main content
Figure 2 | AIDS Research and Therapy

Figure 2

From: Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia

Figure 2

Percentages of patients with virologic success (plasma HIV RNA < 50 copies/ml) with 95% confidence interval (95% CI) overtime on HAART. HIV RNA was measured at six month (M6), M18 and M24 of treatment in HIV patients with TB (HIV + TB+) (continuous line) and without TB (HIV + TB- (dotted line) (A), and HIV + TB- patients sub-grouped as those with TST positive (HIV + TST+) (continuous line) and TST negative (HIV + TST-) (dotted line) (B). Percentage of patients with virologic success per follow up visit are shown on the line graphs; n = number of participants per visit.

Back to article page